ClinicalTrials.Veeva

Menu

Dose-dependent Identification of Unique Biomarkers

San Diego State University logo

San Diego State University

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: Pork Consumption

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of the research is to assess the dose-dependent impacts of the consumption of fresh pork on blood-borne metabolites (markers) following the controlled feeding of pork

Full description

Eligible participants will follow 3 randomly ordered 4-week feeding periods varying only with the consumption of 0, 3 or 6 oz of pork or a 50:50 blend of chicken and beef (6, 3 and 0 oz for respective trials to ensure similar total poultry/meat intake among trials).

Enrollment

22 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • generally healthy (i.e., an absence of diagnosed chronic illnesses and inborn metabolic disorders)
  • Age 18-65
  • all races
  • both sexes
  • willingness to comply with the research diet requirements

Exclusion criteria

  • special dietary needs (e.g., vegetarianism, gluten-free, etc.)
  • use of medication known to influence metabolism
  • smoking
  • substance use

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

22 participants in 3 patient groups

0 oz Pork
Experimental group
Description:
Participants receive 0 oz pork and 6 oz 50:50 blend of chicken and beef per day
Treatment:
Dietary Supplement: Pork Consumption
3 oz Pork
Experimental group
Description:
Participants receive 3 oz pork and 3 oz 50:50 blend of chicken and beef per day
Treatment:
Dietary Supplement: Pork Consumption
6 oz Pork
Experimental group
Description:
Participants receive 6 oz pork and 0 oz 50:50 blend of chicken and beef per day
Treatment:
Dietary Supplement: Pork Consumption

Trial contacts and locations

1

Loading...

Central trial contact

Mark Kern, PhD; Shirin Hooshmand, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems